ZYME

Zymeworks Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↑ 5/10
  • Value↓ 0/10
Zymeworks sales and earnings growth
ZYME Growth
Neutral
  • Revenue Y/Y↓ -17.90%
  • EPS Y/Y↑ 8.67%
  • FCF Y/Y↓ 0.74%
Zymeworks gross and profit margin trends
ZYME Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -126.30%
  • ROIC 5Y↓ -12.77%
Zymeworks net debt vs free cash flow
ZYME Risk
Good
  • Debt / Equity↓ 1.6
  • Debt / FCF↓ 0.3
  • Interest coverage↓ -49.3

Zymeworks stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Biotechnology stocks